Bayer Says Stem Cell Therapy Improves Parkinson’s Disease Symptoms In Initial Trial

Reuters (8/28, Burger) reports, “Bayer said an experimental stem cell therapy developed by its U.S. subsidiary BlueRock had shown signs of easing Parkinson’s disease symptoms in an early 12-patient trial.” Bayer on Monday “said that one year after the tre...